Industry: 'Learn From COVID And Cut EU Drug Review Times'

Change Could Help In Reimbursement And Access Decisions

 
• By Ian Schofield
New oncology drugs could benefit from faster EU decision-making • Source: Alamy

More from Europe

More from Geography